Calretinin is essential for mesothelioma cell growth/survival in vitro: A potential new target for malignant mesothelioma therapy?
-
Blum, Walter
Anatomy, Department of Medicine, University of Fribourg, Switzerland
-
Schwaller, Beat
Anatomy, Department of Medicine, University of Fribourg, Switzerland
Published in:
- International Journal of Cancer. - 2013, p. –
English
Malignant mesothelioma (MM) are highly aggressive asbestos-related neoplasms, which show strong chemotherapy-resistance and there is no effective cure for MM so far. Calretinin (CR) is widely used as a diagnostic marker for epithelioid and mixed (biphasic) mesothelioma, but still little is known about CR's putative function(s) in tumorigenesis. CR protects against asbestos-induced acute cytotoxicity mediated by the AKT/PI3K pathway and furthermore, SV40 early region genes are able to up-regulate CR in mesothelial cells. However, the precise role of CR in mesothelioma is still unknown. Down-regulation of CR via lentiviral-mediated shRNA significantly decreased the viability and proliferation of mesothelioma cells in vitro. The effect was strong in epithelioid-dominated cell lines (ZL55, MSTO-211H). A weaker and delayed effect was observed in mesothelioma cells with prevalent sarcomatoid morphology (SPC111, SPC212, ZL34). The specificity of the effect was confirmed by stable eGFP-CR expression in mesothelioma cell lines and subsequent down-regulation. Depletion of CR led these cancer cell lines to enter apoptosis within 72h post-infection via strong activation of the intrinsic caspase 9-dependent pathway. Down-regulation of CR in immortalized mesothelial cells LP9/TERT-1 strongly blocked proliferation and caused a G₁ block without decreasing viability or activating apoptosis pathways. Our results demonstrate that down-regulation of CR had a strong effect on the viability of MM cells and that CR is essential for cells derived from malignant mesothelioma. We anticipate these findings to reveal calretinin as a highly interesting new putative therapeutic target for mesothelioma treatment of especially the epithelioid, but also of the mixed and sarcomatoid type.
-
Faculty
- Faculté des sciences et de médecine
-
Department
- Département de Médecine
-
Language
-
-
Classification
-
Biological sciences
-
License
-
License undefined
-
Identifiers
-
-
Persistent URL
-
https://folia.unifr.ch/unifr/documents/303021
Statistics
Document views: 37
File downloads: